Evelien D. V. K.
- Country
- The Netherlands
- Department
- NO
Research Overview
- Efficacy and Safety of Tovorafenib in Children and Young Adults with Newly Diagnosed or Recurrent Craniopharyngioma
- Evaluation of Extended Fosaprepitant Prophylaxis for Delayed Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients: A Double-Blind, Placebo-Controlled, Crossover Phase III Trial
Data & Insights
Has run more than one trial at 1 of 3 partner sites.
Specializations
Supportive Cancer Care
The investigator specializes in managing chemotherapy-induced nausea and vomiting (CINV) in pediatric oncology patients, with particular emphasis on developing optimal antiemetic protocols.
- Pediatric CINV Management
- Antiemetic Prophylaxis
- Delayed CINV Prevention
Their research focuses on enhancing supportive care measures for children receiving moderate to highly emetogenic chemotherapy treatments.
Pediatric Oncology
The investigator concentrates on improving quality of life during cancer treatment for pediatric patients, with specific attention to managing treatment-related side effects.
- Treatment Tolerance Optimization
- Supportive Care Protocols
- Patient Comfort Management
Their work encompasses the development of evidence-based approaches for managing chemotherapy side effects in children.
Clinical Pharmacology
The investigator examines antiemetic medication efficacy and optimal duration of prophylactic treatments in pediatric cancer patients.
- Antiemetic Protocol Development
- Treatment Duration Optimization
- Medication Timing Studies
Their research aims to establish more effective protocols for antiemetic medication administration in pediatric oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.